DGX vs RDNT
As of Sep 20, 2026, Quest Diagnostics (DGX) scores 6.8/10 and RadNet (RDNT) 4.6/10 on AlphaStocks' five-model composite, so DGX scores higher. DGX trades 24% above its model fair value; RDNT trades 66% above its model fair value.
DGX
QUEST DIAGNOSTICS INC
6.8
Consider Buy
$246.52
RDNT
RadNet, Inc.
4.6
Weak
$75.97
DGX vs RDNT: Which is the Better Investment?
QUEST DIAGNOSTICS INC (DGX) scores 6.8/10 while RadNet, Inc. (RDNT) scores 4.6/10 on AlphaStocks' composite model. QUEST DIAGNOSTICS INC has the higher composite rating of Consider Buy.
This comparison is algorithmically generated and is not financial advice.
| Metric | DGX | RDNT |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.8/10▲ | 4.6/10 |
| Rating | Consider Buy▲ | Weak |
| Price | $246.52 | $75.97 |
| P/E Ratio | 28.1 | — |
| ROE | 13.8%▲ | -1.7% |
| Market Cap | $28B | $6B |
| Fair Value | $199.57 | $45.80 |
| Dividend Yield | 1.5% | — |
| Sector Rank | #17 of 168▲ | #124 of 168 |
| Model Verdicts | ||
| Piotroski | Strong▲ | Neutral |
| Buffett | Attractive▲ | Caution |
| Graham | Caution | Caution |
| Lynch | Neutral▲ | Caution |
| Greenblatt | Attractive▲ | Neutral |
Related comparisons
DGX vs RDNT: Which Stock Scores Higher?
QUEST DIAGNOSTICS INC (DGX) and RadNet, Inc. (RDNT) are both in the Health Care sector. DGX currently leads with a composite score of 6.8/10 (Consider Buy) compared to RDNT's 4.6/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer